May 7 |
Masimo (MASI) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
May 7 |
Masimo Corp (MASI) Q1 2024 Earnings: Surpasses Revenue Estimates, Aligns with EPS Projections
|
May 7 |
Masimo Non-GAAP EPS of $0.77 beats by $0.07, revenue of $492.8M beats by $5.08M
|
May 7 |
Masimo Reports First Quarter 2024 Financial Results
|
May 7 |
Masimo’s at-home baby monitor cleared for use without prescription
|
May 6 |
Masimo Q1 2024 Earnings Preview
|
May 6 |
Masimo Receives FDA Clearance for Stork™ Over-the-Counter (OTC) Baby Monitoring System
|
May 5 |
Baron Funds - Masimo Corp.: Can Potentially Double Our Investment
|
Apr 30 |
Masimo Insider Ups Holding During Year
|
Apr 25 |
Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024
|